Home Word on the street Analyst Price Target

Analyst Price Target

Acreage Holdings: Analysts’ Target Price and Ratings

0
Acreage Holdings (ACRGF) is a US-based cannabis company with licenses to operate and provide consulting services in the US. The stock has fallen drastically...

KushCo Holdings: Analysts’ Target Price and Ratings

0
KushCo Holdings’ (KSHB) stock price has been under pressure since it reported its third-quarter earnings on July 9. As of September 27, the company...

Curaleaf: Analysts’ Target Price and Ratings

0
Curaleaf (CURLF) reported its second-quarter earnings results on August 28. The stock has fallen 6.3% since then. In September, the company announced the launch...

OrganiGram: Analysts’ Target Price and Ratings

0
OrganiGram Holdings (OGI) stock has been under pressure since it reported its third-quarter earnings on July 15. As of Wednesday, the company was trading...

Supreme Cannabis: Analysts’ Target Price and Ratings

0
Supreme Cannabis (FIRE) reported its fourth-quarter earnings on September 17. The company reported revenue growth of 90% from its third-quarter revenues. In addition, Supreme...

Aphria: Analysts’ Target Price and Ratings

0
Aphria (APHA) stock has gained since it reported strong fourth-quarter results in August. The stock has gained 9.6% since its earnings. Let’s take a...

HEXO: Analysts’ Target Price and Ratings

0
HEXO (HEXO) stock has fallen since its dismal third-quarter performance. The company reported its results in June. However, the stock got a boost on...

Cronos Group: Analysts’ Price Target and Ratings

0
A total of 12 analysts have been covering Cronos Group (CRON) (CRON) in August and September. In contrast, 13 analysts covered the stock in...

TGOD: Why Analysts Lowered Price Targets in September

0
Higher net losses and Aurora selling its stake in TGOD appear to have prompted analysts to lower their price targets.

Curaleaf Holdings: Analysts’ Recommendations

0
Analysts’ recommendations Among the six analysts that follow Curaleaf Holdings (CURA) (CURLF), three recommended a “strong buy,” while three recommended a “buy.” Analysts have given Curaleaf a 12-month...

Must Read

Tilray’s Latest Ratings: Analysts Are Undecided

0
Tilray has frequently been in the news lately. Despite its efforts, its stock has continued to fall for the last month. It's currently trading at $17.31.

Coming Back to Life at O’Keeffe’s Ghost Ranch

0
Ghost Ranch Casa de Sol photo by Jamie Clifford. The Art of Asana in Abiquiu’s Ghost Ranch My partner Jeff and I were...

Tilray Exports to Switzerland and 13 Other Countries

0
In recent news, Tilray Inc. (TLRY) exported medical marijuana to Switzerland. The company exported medical marijuana extracts to cater to the needs of patients...
Sitemap